Misplaced Pages

The following pages link to ATC code L04

• (link count
• transclusion count
• sorted list) · See help page for transcluding these entries

Showing 50 items.

• QL04 (redirect page) (links | edit)
• ATCvet code QL04 (redirect page) (links | edit)
• Umirolimus (links | edit)
• Briakinumab (links | edit)
• Pegsunercept (links | edit)
• Pirfenidone (links | edit)
• Tilomisole (links | edit)
• ATC code L04A (redirect to section "L04A") (links | edit)
• ATCvet code QL04A (redirect to section "L04A") (links | edit)
• ATC code L04AA (redirect to section "L04AA") (links | edit)
  • Sphingosine-1-phosphate receptor modulator (links | edit)
• ATCvet code QL04AA (redirect to section "L04AA") (links | edit)
• ATC code L04AB (redirect to section "L04AB") (links | edit)
• ATCvet code QL04AB (redirect to section "L04AB") (links | edit)
• ATC code L04AC (redirect to section "L04AC") (links | edit)
• ATCvet code QL04AC (redirect to section "L04AC") (links | edit)
• ATC code L04AD (redirect to section "L04AD") (links | edit)
• ATCvet code QL04AD (redirect to section "L04AD") (links | edit)
• ATC code L04AX (redirect to section "L04AX") (links | edit)
  • Cereblon E3 ligase modulator (links | edit)
  • User:HlynurT/Discovery and development of thalidomide and its analogs (links | edit)
• ATCvet code QL04AX (redirect to section "L04AX") (links | edit)
• Tofacitinib (links | edit)
• Brodalumab (links | edit)
• Ixekizumab (links | edit)
• Secukinumab (links | edit)
• Sirukumab (links | edit)
• Teprotumumab (links | edit)
• Sarilumab (links | edit)
• Ublituximab (links | edit)
• Olokizumab (links | edit)
• BMS-470539 (links | edit)
• Baricitinib (links | edit)
• Apremilast (links | edit)
• Tildrakizumab (links | edit)
• MTOR inhibitors (links | edit)
• Voclosporin (links | edit)
• Guselkumab (links | edit)
• Anifrolumab (links | edit)
• Cereblon E3 ligase modulator (links | edit)
• Ponesimod (links | edit)
• Filgotinib (links | edit)
• Ozanimod (links | edit)
• Siponimod (links | edit)
• Risankizumab (links | edit)
• Inebilizumab (links | edit)
• Emapalumab (links | edit)
• Peficitinib (links | edit)
• Upadacitinib (links | edit)
• Mirikizumab (links | edit)
• Ravulizumab (links | edit)
• Belumosudil (links | edit)
• Bimekizumab (links | edit)